News + Resources

Keep up with the latest

Featured

This Scientist Is Building Custom Gene-Editing Tools

This Scientist Is Building Custom Gene-Editing Tools

Epigenetic editors are a gentler form of gene editing

February 24, 2025

The Economist

Epigenetic editors are a gentler form of gene editing

February 24, 2025

Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024

November 25, 2024

Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024

November 25, 2024

CRISPR 2.0, the Next Generation

June 21, 2024

Aspen Ideas: Health

CRISPR 2.0, the Next Generation

June 21, 2024

The Age of CRISPR: Engineering the Future of Genetic Medicine

February 23, 2024

TEDxBerkeley

The Age of CRISPR: Engineering the Future of Genetic Medicine

February 23, 2024

All Stories

All
News
Press Releases
News

CRISPRMED25 Virtual Event Roundup

April 8, 2025

CRISPR Medicine News

Read Now
News

From Tools to Trials: Editing Therapy Companies Pivot to Development

March 20, 2025

Genetic Engineering & Biotechnology News

Read Now
News

Epigenetic editors are a gentler form of gene editing

February 24, 2025

The Economist

Read Now
News

CRISPR’s cardio catch-all drives a biotech’s broad potential

February 18, 2025

PharmaVoice

Read Now
News

Towards an AI-Driven CRISPR Future

February 11, 2025

SynBioBeta

Read Now
News

2025 predictions: Which trends are set to shape the biotech industry this year?

January 13, 2025

Labiotech

Read Now
Press release

Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024

November 25, 2024

Read Now
Press release

Scribe Therapeutics to Present Preclinical Data on CRISPR Genome and Epigenome Editing Technologies at American Heart Association (AHA) Scientific Sessions 2024

October 30, 2024

Read Now
Press release

Scribe Therapeutics to Participate in Upcoming Conferences

September 12, 2024

Read Now
Press release

Scribe Therapeutics Presents Data Demonstrating Highly Potent Gene Editing In Vivo, Including Saturated Editing of Hepatocytes in NHPs, by an Engineered XE Genome Editor; Showcases Novel Epigenetic Editing Capabilities at 2024 ASGCT Annual Meeting

May 10, 2024

Read Now
Press release

Scribe Therapeutics to Present on Advances in CRISPR Genome and Epigenome Editing at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

April 22, 2024

Read Now
Press release

Scribe Therapeutics to Participate in the Leerink Partners Global Biopharma Conference

March 6, 2024

Read Now

Publications and presentations